Start Date
January 31, 2012
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
TC-5214
Single oral dose of 2 mg
TC-5214 Placebo
Single oral dose
Ketamine
Single oral dose of 100 mg
Phentermine
Single oral dose of 45 mg
TC-5214
Single oral dose of 8 mg
TC-5214
Single oral dose of 16 mg
Phentermine
Single oral dose of 90 mg
Lead Sponsor
AstraZeneca
INDUSTRY